PATENT CLAIM ANALYSIS

Application Number: 15767320
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "282000"]

Abstract:
A novel ethylene glycol ether of buprenorphine for oral administration and its the treatment of chronic pain.

Claim (Index 6):
A method for the treatment of chronic pain comprising orally administering to a subject a therapeutically effective amount of a composition according to  claim 2 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14922373', '14697174', '15074960', '14697155', '11888955']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7440190578030808
- 35 USC 102 Novelty (BERT): 0.5013822005738834
- Combined Prediction Score: 0.719755372080161
- Mean Citation Score: 197.604068
- Max Citation Score: 204.42125
- Similarity Product: 125.37258132450282

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test